AMN Healthcare Services, Inc. (AMN)
| Market Cap | 1.07B +38.2% |
| Revenue (ttm) | 3.42B +19.9% |
| Net Income | -32.44M |
| EPS | -0.84 |
| Shares Out | 38.79M |
| PE Ratio | n/a |
| Forward PE | 32.84 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,106,331 |
| Open | 25.90 |
| Previous Close | 25.65 |
| Day's Range | 25.84 - 27.69 |
| 52-Week Range | 14.87 - 31.65 |
| Beta | 0.30 |
| Analysts | Hold |
| Price Target | 28.14 (+1.74%) |
| Earnings Date | May 7, 2026 |
About AMN
AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, ... [Read more]
Financial Performance
In 2025, AMN Healthcare Services's revenue was $2.73 billion, a decrease of -8.49% compared to the previous year's $2.98 billion. Losses were -$95.70 million, -34.89% less than in 2024.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for AMN stock is "Hold." The 12-month stock price target is $28.14, which is an increase of 1.74% from the latest price.
News
AMN Healthcare Services Transcript: Bank of America Global Healthcare Conference 2026
Market demand and bill rates have stabilized post-pandemic, with several business lines returning to growth and others expected to follow by 2027. Strategic investments in technology, AI, and operational improvements are driving efficiency, margin recovery, and market share gains.
Eric Palmer Joins AMN Healthcare Board of Directors
DALLAS, May 13, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of Director...
AMN Healthcare price target raised to $32 from $19.50 at UBS
UBS analyst AJ Rice raised the firm’s price target on AMN Healthcare (AMN) to $32 from $19.50 and keeps a Neutral rating on the shares. The firm updated its model…
AMN Healthcare price target raised to $26 from $25 at BMO Capital
BMO Capital raised the firm’s price target on AMN Healthcare (AMN) to $26 from $25 and keeps an Outperform rating on the shares. The company’s Q1 upside was boosted by…
AMN Healthcare price target raised to $26 from $23 at Baird
Baird raised the firm’s price target on AMN Healthcare (AMN) to $26 from $23 and keeps a Neutral rating on the shares. The firm updated its model following strong Q1…
AMN Healthcare Services Q1 Earnings Call Highlights
AMN Healthcare Services NYSE: AMN reported first-quarter 2026 revenue well above its guidance range, driven by unusually large labor disruption activity, while management said several core businesses ...
AMN Healthcare price target raised to $26 from $24 at Truist
Truist analyst Tobey Sommer raised the firm’s price target on AMN Healthcare (AMN) to $26 from $24 and keeps a Buy rating on the shares after its Q1 earnings beat,…
AMN Healthcare Services Slides: Investor presentation
AMN Healthcare Services has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
AMN Healthcare Services Earnings Call Transcript: Q1 2026
Q1 2026 saw record revenue and margin outperformance, driven by major labor disruption events and strong execution in core staffing segments. Guidance anticipates normalization in Q2, with continued growth in international and allied staffing, and a stable leverage profile.
AMN Healthcare Services Earnings release: Q1 2026
AMN Healthcare Services released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
AMN Healthcare Services Slides: Q1 2026
AMN Healthcare Services has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
AMN Healthcare Services Quarterly report: Q1 2026
AMN Healthcare Services has published its Q1 2026 quarterly earnings report on May 7, 2026.
AMN Healthcare Announces First Quarter 2026 Results
Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million ; GAAP income of $1.59 /share and adjusted EPS of $2.10 DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. ...
AMN Healthcare Services Transcript: AGM 2026
The meeting covered director elections, executive compensation, auditor ratification, and equity plan amendment, with all board proposals passing. A shareholder proposal for an independent board chairman was discussed but did not pass. Technology initiatives and travel nurse segment trends were also addressed.
AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2026 financial results and second quarter 2026 outloo...
AMN Healthcare Services Proxy statement: Proxy Filing
AMN Healthcare Services filed a proxy statement on March 18, 2026, providing details for shareholder voting and corporate governance matters.
AMN Healthcare Services Proxy statement: Proxy Filing
AMN Healthcare Services filed a proxy statement on March 18, 2026, providing details for shareholder voting and corporate governance matters.
AMN Healthcare Survey Reveals Sharp Divide Between Leaders' Organizational Confidence and Industry Outlook for 2026
Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag Survey of 700+ executives shows AI leadership roles surging as succession planning and c...
AMN Healthcare price target raised to $24 from $22 at Citizens
Citizens analyst Constantine Davides raised the firm’s price target on AMN Healthcare (AMN) to $24 from $22 and keeps an Outperform rating on the shares. AMN Healthcare may deserve increased…
AMN Healthcare price target raised to $19.50 from $19 at UBS
UBS raised the firm’s price target on AMN Healthcare (AMN) to $19.50 from $19 and keeps a Neutral rating on the shares.
AMN Healthcare price target raised to $23 from $21 at Baird
Baird analyst Mark Marcon raised the firm’s price target on AMN Healthcare (AMN) to $23 from $21 and keeps a Neutral rating on the shares. The firm updated its model…
UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Quarterly revenue of $748 million ; GAAP loss of ($0.20) /share and adjusted EPS of $0.22
AMN Healthcare Services Earnings Call Transcript: Q4 2025
Q4 2025 saw revenue growth driven by labor disruption events, with full year revenue at $2.73B and significant debt reduction. Guidance for Q1 2026 includes $600M in labor disruption revenue, while underlying business trends remain stable and long-term growth targets are 4%-6% annually.
AMN Healthcare Services Annual report: Q4 2025
AMN Healthcare Services has published its Q4 2025 annual report on February 19, 2026.
AMN Healthcare Services Earnings release: Q4 2025
AMN Healthcare Services released its Q4 2025 earnings on February 19, 2026, summarizing the period's financial results.